Study details
Enrolling now
Effectiveness of Two Aspirin Doses for Prevention of Hypertensive Disorders of Pregnancy: ASPIRIN TRIAL
Ohio State University
NCT IDNCT06468202ClinicalTrials.gov data as of Apr 2026
Phase
Phase 4
Target enrollment
10,742
Study length
about 5.3 years
Ages
14–35
Sex
Female only
Locations
16 sites in AL, CA, IL +11
About this study
This trial is testing whether 162 mg of aspirin daily is better than 81 mg of aspirin daily in preventing hypertensive disorders of pregnancy. The goal is to understand factors that affect how well women take the aspirin and use this information to improve care for pregnant women at risk.
Based on ClinicalTrials.gov records.
What participants do
- 1.Take Aspirin 162 mg
- 2.Take Aspirin 81 mg
PhasePhase 4
DrugAspirin 162 mg
Routeoral
Participation effort
Estimated from trial records. Details can vary by site.
Time + visits
Low11%
Logistics
Moderate50%
Logistics difficulty varies by site location and availability.
Trial highlights
Treatment details
Auto-extracted from trial records to preview treatments and outcomes.
Drug classes
acetylsalicylic acid
Drug routes
oral (Delayed Release Oral Tablet)
Body systems
Reproductive Health, Cardiology / Heart